These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20659028)

  • 21. [Heart failure. 2: Therapy].
    Morf S; Hochuli M; Elke B; Noll G
    Praxis (Bern 1994); 2010 Jan; 99(2):83-91; quiz 92-3. PubMed ID: 20087825
    [No Abstract]   [Full Text] [Related]  

  • 22. Heart failure drugs: what's new?
    Drug Ther Bull; 2000 Apr; 38(4):25-7. PubMed ID: 10845239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacologic treatment of heart failure in the elderly].
    Erdmann E
    Dtsch Med Wochenschr; 2013 Apr; 138(14):700-2. PubMed ID: 23533033
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of heart failure and preserved systolic function].
    Dahlström U; Boman K; Brodin LA; Hagerman I; Willenheimer R
    Lakartidningen; 2007 Aug 22-28; 104(34):2348-50. PubMed ID: 17907560
    [No Abstract]   [Full Text] [Related]  

  • 25. Medication adherence in patients with heart failure and a depressed ejection fraction attending cardiology clinics.
    Crespo Leiro MG; Murga N; Matalí A; López-Sendón JL
    Rev Esp Cardiol; 2009 Apr; 62(4):454-5. PubMed ID: 19401134
    [No Abstract]   [Full Text] [Related]  

  • 26. What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Tajik AA; Dickstein K
    Heart; 2016 Dec; 102(23):1922-1932. PubMed ID: 27742799
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
    Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
    Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug treatment of chronic heart failure].
    Böhm M; Werner N; Kindermann M
    Clin Res Cardiol; 2006; 95 Suppl 4():36-54; quiz 55-6. PubMed ID: 16598606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing patients with heart failure.
    Ammon S
    Am J Nurs; 2001 Dec; 101(12):34-40. PubMed ID: 12585064
    [No Abstract]   [Full Text] [Related]  

  • 30. [ACE inhibitors, beta blockers, AT-1 antagonists in heart failure. Right dosage and combination].
    Fliri M
    MMW Fortschr Med; 2002 Nov; 144(48):38-43. PubMed ID: 12532542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for choosing drugs in chronic heart failure.
    Tabrizchi R
    Vasc Health Risk Manag; 2005; 1(3):171-2. PubMed ID: 17319102
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of heart failure due to systolic dysfunction].
    Jiménez-Navarro MF; García-Pinilla JM; Montiel Trujillo A; de Teresa Galván E
    Rev Esp Cardiol; 2006 Jul; 6 Suppl F():46-52. PubMed ID: 17144976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients.
    Orea-Tejeda A; Colín-Ramírez E; Castillo-Martínez L; Asensio-Lafuente E; Corzo-León D; González-Toledo R; Rebollar-González V; Narváez-David R; Dorantes-García J
    Rev Invest Clin; 2007; 59(2):103-7. PubMed ID: 17633796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling.
    Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE
    Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN; Mareev VIu; Skvortsov AA
    Ter Arkh; 2008; 80(9):5-12. PubMed ID: 19555028
    [No Abstract]   [Full Text] [Related]  

  • 36. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.
    Komajda M; Lapuerta P; Hermans N; Gonzalez-Juanatey JR; van Veldhuisen DJ; Erdmann E; Tavazzi L; Poole-Wilson P; Le Pen C
    Eur Heart J; 2005 Aug; 26(16):1653-9. PubMed ID: 15827061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Heart failure update 2010 and current ESC guidelines].
    Hoppe UC; Erdmann E
    Herz; 2010 Dec; 35(8):535-40. PubMed ID: 21052612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based treatment of chronic heart failure.
    Rosen D; Decaro MV; Graham MG
    Compr Ther; 2007; 33(1):2-17. PubMed ID: 17984487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New therapies for heart failure.
    Riggs JM
    RN; 2004 Mar; 67(3):28-32; quiz 33. PubMed ID: 15065491
    [No Abstract]   [Full Text] [Related]  

  • 40. [The preoperative care in noncardiac surgery of patients with heart failure].
    Böhm M
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S70-6. PubMed ID: 10535050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.